Merck KGaA has shown off data that fueled its $85 million bet on a late-phase treatment for a rare, locally aggressive tumor.

Ares Commercial Finance ("ACF") announced today that it has provided a $15 million senior secured revolving line of credit to Shimmick Corporation ("Shimmick" or the "Company"), an Irvine, ...

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono"), today announced that the results from the open label Phase 2 PROSPECT Study of tirabrutinib is to be ...

During a live event, Samuel M. Rubinstein, MD, discussed the efficacy and safety outcomes from the KarMMa-3 trial.

BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing cancer therapies, today announces that it will have a poster ...

The FDA has approved the VENTANA MET (SP44) RxDx Assay as a companion diagnostic to identify individuals with non–small cell lung cancer (NSCLC) and high c-Met protein overexpression who may be ...

The newest additions to the OnePlus Ace family are phenomenally well-equipped, insanely affordable, and alas, exclusive to ...

In Season 25 of Apex Legends, the strongest characters are Lifeline, Newcastle, Ash, and Alter! Here's why and how to use ...

Immunomics explores the regulation of the immune system by leveraging emerging omics sciences to decipher the intricate ...